Medical Care
Global 1-Deoxynojirimycin Market Research Report 2025
- Mar 13, 25
- ID: 132453
- Pages: 116
- Figures: 108
- Views: 49
The global market for 1-Deoxynojirimycin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for 1-Deoxynojirimycin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for 1-Deoxynojirimycin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of 1-Deoxynojirimycin include TOKYO CHEMICAL INDUSTRY (TCI), Merck, Alfa Aesar, Biosynth, Glentham Life Sciences, LGC Group, MedChemExpress, Cayman Chemical, ALB Materials, PhytoLab, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for 1-Deoxynojirimycin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 1-Deoxynojirimycin.
The 1-Deoxynojirimycin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 1-Deoxynojirimycin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 1-Deoxynojirimycin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
TOKYO CHEMICAL INDUSTRY (TCI)
Merck
Alfa Aesar
Biosynth
Glentham Life Sciences
LGC Group
MedChemExpress
Cayman Chemical
ALB Materials
PhytoLab
TargetMol
Fluorochem
Yunmei Technology
TLC Pharmaceutical Standards
Apollo Scientific
Macklin
Chengdu Must Bio-technology
Bidepharm
Geneham Pharmaceutical
AstaTech
Combi-Blocks
Pharmablock
Segment by Type
95%-98% (Including 95% and 98%)
Above 98%
Segment by Application
Scientific Research
Anti-diabetic Drugs
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 1-Deoxynojirimycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of 1-Deoxynojirimycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
North American market for 1-Deoxynojirimycin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for 1-Deoxynojirimycin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of 1-Deoxynojirimycin include TOKYO CHEMICAL INDUSTRY (TCI), Merck, Alfa Aesar, Biosynth, Glentham Life Sciences, LGC Group, MedChemExpress, Cayman Chemical, ALB Materials, PhytoLab, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for 1-Deoxynojirimycin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 1-Deoxynojirimycin.
The 1-Deoxynojirimycin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 1-Deoxynojirimycin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 1-Deoxynojirimycin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
TOKYO CHEMICAL INDUSTRY (TCI)
Merck
Alfa Aesar
Biosynth
Glentham Life Sciences
LGC Group
MedChemExpress
Cayman Chemical
ALB Materials
PhytoLab
TargetMol
Fluorochem
Yunmei Technology
TLC Pharmaceutical Standards
Apollo Scientific
Macklin
Chengdu Must Bio-technology
Bidepharm
Geneham Pharmaceutical
AstaTech
Combi-Blocks
Pharmablock
Segment by Type
95%-98% (Including 95% and 98%)
Above 98%
Segment by Application
Scientific Research
Anti-diabetic Drugs
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 1-Deoxynojirimycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of 1-Deoxynojirimycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 1-Deoxynojirimycin Market Overview
1.1 Product Definition
1.2 1-Deoxynojirimycin by Type
1.2.1 Global 1-Deoxynojirimycin Market Value Comparison by Type (2024 VS 2031)
1.2.2 95%-98% (Including 95% and 98%)
1.2.3 Above 98%
1.3 1-Deoxynojirimycin by Application
1.3.1 Global 1-Deoxynojirimycin Market Value by Application (2024 VS 2031)
1.3.2 Scientific Research
1.3.3 Anti-diabetic Drugs
1.3.4 Others
1.4 Global 1-Deoxynojirimycin Market Size Estimates and Forecasts
1.4.1 Global 1-Deoxynojirimycin Revenue 2020-2031
1.4.2 Global 1-Deoxynojirimycin Sales 2020-2031
1.4.3 Global 1-Deoxynojirimycin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 1-Deoxynojirimycin Market Competition by Manufacturers
2.1 Global 1-Deoxynojirimycin Sales Market Share by Manufacturers (2020-2025)
2.2 Global 1-Deoxynojirimycin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global 1-Deoxynojirimycin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of 1-Deoxynojirimycin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of 1-Deoxynojirimycin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 1-Deoxynojirimycin, Product Type & Application
2.7 Global Key Manufacturers of 1-Deoxynojirimycin, Date of Enter into This Industry
2.8 Global 1-Deoxynojirimycin Market Competitive Situation and Trends
2.8.1 Global 1-Deoxynojirimycin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest 1-Deoxynojirimycin Players Market Share by Revenue
2.8.3 Global 1-Deoxynojirimycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global 1-Deoxynojirimycin Market Scenario by Region
3.1 Global 1-Deoxynojirimycin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global 1-Deoxynojirimycin Sales by Region: 2020-2031
3.2.1 Global 1-Deoxynojirimycin Sales by Region: 2020-2025
3.2.2 Global 1-Deoxynojirimycin Sales by Region: 2026-2031
3.3 Global 1-Deoxynojirimycin Revenue by Region: 2020-2031
3.3.1 Global 1-Deoxynojirimycin Revenue by Region: 2020-2025
3.3.2 Global 1-Deoxynojirimycin Revenue by Region: 2026-2031
3.4 North America 1-Deoxynojirimycin Market Facts & Figures by Country
3.4.1 North America 1-Deoxynojirimycin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America 1-Deoxynojirimycin Sales by Country (2020-2031)
3.4.3 North America 1-Deoxynojirimycin Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe 1-Deoxynojirimycin Market Facts & Figures by Country
3.5.1 Europe 1-Deoxynojirimycin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe 1-Deoxynojirimycin Sales by Country (2020-2031)
3.5.3 Europe 1-Deoxynojirimycin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 1-Deoxynojirimycin Market Facts & Figures by Region
3.6.1 Asia Pacific 1-Deoxynojirimycin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific 1-Deoxynojirimycin Sales by Region (2020-2031)
3.6.3 Asia Pacific 1-Deoxynojirimycin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America 1-Deoxynojirimycin Market Facts & Figures by Country
3.7.1 Latin America 1-Deoxynojirimycin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America 1-Deoxynojirimycin Sales by Country (2020-2031)
3.7.3 Latin America 1-Deoxynojirimycin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa 1-Deoxynojirimycin Market Facts & Figures by Country
3.8.1 Middle East and Africa 1-Deoxynojirimycin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa 1-Deoxynojirimycin Sales by Country (2020-2031)
3.8.3 Middle East and Africa 1-Deoxynojirimycin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 1-Deoxynojirimycin Sales by Type (2020-2031)
4.1.1 Global 1-Deoxynojirimycin Sales by Type (2020-2025)
4.1.2 Global 1-Deoxynojirimycin Sales by Type (2026-2031)
4.1.3 Global 1-Deoxynojirimycin Sales Market Share by Type (2020-2031)
4.2 Global 1-Deoxynojirimycin Revenue by Type (2020-2031)
4.2.1 Global 1-Deoxynojirimycin Revenue by Type (2020-2025)
4.2.2 Global 1-Deoxynojirimycin Revenue by Type (2026-2031)
4.2.3 Global 1-Deoxynojirimycin Revenue Market Share by Type (2020-2031)
4.3 Global 1-Deoxynojirimycin Price by Type (2020-2031)
5 Segment by Application
5.1 Global 1-Deoxynojirimycin Sales by Application (2020-2031)
5.1.1 Global 1-Deoxynojirimycin Sales by Application (2020-2025)
5.1.2 Global 1-Deoxynojirimycin Sales by Application (2026-2031)
5.1.3 Global 1-Deoxynojirimycin Sales Market Share by Application (2020-2031)
5.2 Global 1-Deoxynojirimycin Revenue by Application (2020-2031)
5.2.1 Global 1-Deoxynojirimycin Revenue by Application (2020-2025)
5.2.2 Global 1-Deoxynojirimycin Revenue by Application (2026-2031)
5.2.3 Global 1-Deoxynojirimycin Revenue Market Share by Application (2020-2031)
5.3 Global 1-Deoxynojirimycin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 TOKYO CHEMICAL INDUSTRY (TCI)
6.1.1 TOKYO CHEMICAL INDUSTRY (TCI) Company Information
6.1.2 TOKYO CHEMICAL INDUSTRY (TCI) Description and Business Overview
6.1.3 TOKYO CHEMICAL INDUSTRY (TCI) 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 TOKYO CHEMICAL INDUSTRY (TCI) 1-Deoxynojirimycin Product Portfolio
6.1.5 TOKYO CHEMICAL INDUSTRY (TCI) Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck 1-Deoxynojirimycin Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Alfa Aesar
6.3.1 Alfa Aesar Company Information
6.3.2 Alfa Aesar Description and Business Overview
6.3.3 Alfa Aesar 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Alfa Aesar 1-Deoxynojirimycin Product Portfolio
6.3.5 Alfa Aesar Recent Developments/Updates
6.4 Biosynth
6.4.1 Biosynth Company Information
6.4.2 Biosynth Description and Business Overview
6.4.3 Biosynth 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biosynth 1-Deoxynojirimycin Product Portfolio
6.4.5 Biosynth Recent Developments/Updates
6.5 Glentham Life Sciences
6.5.1 Glentham Life Sciences Company Information
6.5.2 Glentham Life Sciences Description and Business Overview
6.5.3 Glentham Life Sciences 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Glentham Life Sciences 1-Deoxynojirimycin Product Portfolio
6.5.5 Glentham Life Sciences Recent Developments/Updates
6.6 LGC Group
6.6.1 LGC Group Company Information
6.6.2 LGC Group Description and Business Overview
6.6.3 LGC Group 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 LGC Group 1-Deoxynojirimycin Product Portfolio
6.6.5 LGC Group Recent Developments/Updates
6.7 MedChemExpress
6.7.1 MedChemExpress Company Information
6.7.2 MedChemExpress Description and Business Overview
6.7.3 MedChemExpress 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 MedChemExpress 1-Deoxynojirimycin Product Portfolio
6.7.5 MedChemExpress Recent Developments/Updates
6.8 Cayman Chemical
6.8.1 Cayman Chemical Company Information
6.8.2 Cayman Chemical Description and Business Overview
6.8.3 Cayman Chemical 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cayman Chemical 1-Deoxynojirimycin Product Portfolio
6.8.5 Cayman Chemical Recent Developments/Updates
6.9 ALB Materials
6.9.1 ALB Materials Company Information
6.9.2 ALB Materials Description and Business Overview
6.9.3 ALB Materials 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 ALB Materials 1-Deoxynojirimycin Product Portfolio
6.9.5 ALB Materials Recent Developments/Updates
6.10 PhytoLab
6.10.1 PhytoLab Company Information
6.10.2 PhytoLab Description and Business Overview
6.10.3 PhytoLab 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 PhytoLab 1-Deoxynojirimycin Product Portfolio
6.10.5 PhytoLab Recent Developments/Updates
6.11 TargetMol
6.11.1 TargetMol Company Information
6.11.2 TargetMol Description and Business Overview
6.11.3 TargetMol 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 TargetMol 1-Deoxynojirimycin Product Portfolio
6.11.5 TargetMol Recent Developments/Updates
6.12 Fluorochem
6.12.1 Fluorochem Company Information
6.12.2 Fluorochem Description and Business Overview
6.12.3 Fluorochem 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Fluorochem 1-Deoxynojirimycin Product Portfolio
6.12.5 Fluorochem Recent Developments/Updates
6.13 Yunmei Technology
6.13.1 Yunmei Technology Company Information
6.13.2 Yunmei Technology Description and Business Overview
6.13.3 Yunmei Technology 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Yunmei Technology 1-Deoxynojirimycin Product Portfolio
6.13.5 Yunmei Technology Recent Developments/Updates
6.14 TLC Pharmaceutical Standards
6.14.1 TLC Pharmaceutical Standards Company Information
6.14.2 TLC Pharmaceutical Standards Description and Business Overview
6.14.3 TLC Pharmaceutical Standards 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 TLC Pharmaceutical Standards 1-Deoxynojirimycin Product Portfolio
6.14.5 TLC Pharmaceutical Standards Recent Developments/Updates
6.15 Apollo Scientific
6.15.1 Apollo Scientific Company Information
6.15.2 Apollo Scientific Description and Business Overview
6.15.3 Apollo Scientific 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Apollo Scientific 1-Deoxynojirimycin Product Portfolio
6.15.5 Apollo Scientific Recent Developments/Updates
6.16 Macklin
6.16.1 Macklin Company Information
6.16.2 Macklin Description and Business Overview
6.16.3 Macklin 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Macklin 1-Deoxynojirimycin Product Portfolio
6.16.5 Macklin Recent Developments/Updates
6.17 Chengdu Must Bio-technology
6.17.1 Chengdu Must Bio-technology Company Information
6.17.2 Chengdu Must Bio-technology Description and Business Overview
6.17.3 Chengdu Must Bio-technology 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Chengdu Must Bio-technology 1-Deoxynojirimycin Product Portfolio
6.17.5 Chengdu Must Bio-technology Recent Developments/Updates
6.18 Bidepharm
6.18.1 Bidepharm Company Information
6.18.2 Bidepharm Description and Business Overview
6.18.3 Bidepharm 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Bidepharm 1-Deoxynojirimycin Product Portfolio
6.18.5 Bidepharm Recent Developments/Updates
6.19 Geneham Pharmaceutical
6.19.1 Geneham Pharmaceutical Company Information
6.19.2 Geneham Pharmaceutical Description and Business Overview
6.19.3 Geneham Pharmaceutical 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Geneham Pharmaceutical 1-Deoxynojirimycin Product Portfolio
6.19.5 Geneham Pharmaceutical Recent Developments/Updates
6.20 AstaTech
6.20.1 AstaTech Company Information
6.20.2 AstaTech Description and Business Overview
6.20.3 AstaTech 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.20.4 AstaTech 1-Deoxynojirimycin Product Portfolio
6.20.5 AstaTech Recent Developments/Updates
6.21 Combi-Blocks
6.21.1 Combi-Blocks Company Information
6.21.2 Combi-Blocks Description and Business Overview
6.21.3 Combi-Blocks 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Combi-Blocks 1-Deoxynojirimycin Product Portfolio
6.21.5 Combi-Blocks Recent Developments/Updates
6.22 Pharmablock
6.22.1 Pharmablock Company Information
6.22.2 Pharmablock Description and Business Overview
6.22.3 Pharmablock 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Pharmablock 1-Deoxynojirimycin Product Portfolio
6.22.5 Pharmablock Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 1-Deoxynojirimycin Industry Chain Analysis
7.2 1-Deoxynojirimycin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 1-Deoxynojirimycin Production Mode & Process Analysis
7.4 1-Deoxynojirimycin Sales and Marketing
7.4.1 1-Deoxynojirimycin Sales Channels
7.4.2 1-Deoxynojirimycin Distributors
7.5 1-Deoxynojirimycin Customer Analysis
8 1-Deoxynojirimycin Market Dynamics
8.1 1-Deoxynojirimycin Industry Trends
8.2 1-Deoxynojirimycin Market Drivers
8.3 1-Deoxynojirimycin Market Challenges
8.4 1-Deoxynojirimycin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 1-Deoxynojirimycin by Type
1.2.1 Global 1-Deoxynojirimycin Market Value Comparison by Type (2024 VS 2031)
1.2.2 95%-98% (Including 95% and 98%)
1.2.3 Above 98%
1.3 1-Deoxynojirimycin by Application
1.3.1 Global 1-Deoxynojirimycin Market Value by Application (2024 VS 2031)
1.3.2 Scientific Research
1.3.3 Anti-diabetic Drugs
1.3.4 Others
1.4 Global 1-Deoxynojirimycin Market Size Estimates and Forecasts
1.4.1 Global 1-Deoxynojirimycin Revenue 2020-2031
1.4.2 Global 1-Deoxynojirimycin Sales 2020-2031
1.4.3 Global 1-Deoxynojirimycin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 1-Deoxynojirimycin Market Competition by Manufacturers
2.1 Global 1-Deoxynojirimycin Sales Market Share by Manufacturers (2020-2025)
2.2 Global 1-Deoxynojirimycin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global 1-Deoxynojirimycin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of 1-Deoxynojirimycin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of 1-Deoxynojirimycin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 1-Deoxynojirimycin, Product Type & Application
2.7 Global Key Manufacturers of 1-Deoxynojirimycin, Date of Enter into This Industry
2.8 Global 1-Deoxynojirimycin Market Competitive Situation and Trends
2.8.1 Global 1-Deoxynojirimycin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest 1-Deoxynojirimycin Players Market Share by Revenue
2.8.3 Global 1-Deoxynojirimycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global 1-Deoxynojirimycin Market Scenario by Region
3.1 Global 1-Deoxynojirimycin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global 1-Deoxynojirimycin Sales by Region: 2020-2031
3.2.1 Global 1-Deoxynojirimycin Sales by Region: 2020-2025
3.2.2 Global 1-Deoxynojirimycin Sales by Region: 2026-2031
3.3 Global 1-Deoxynojirimycin Revenue by Region: 2020-2031
3.3.1 Global 1-Deoxynojirimycin Revenue by Region: 2020-2025
3.3.2 Global 1-Deoxynojirimycin Revenue by Region: 2026-2031
3.4 North America 1-Deoxynojirimycin Market Facts & Figures by Country
3.4.1 North America 1-Deoxynojirimycin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America 1-Deoxynojirimycin Sales by Country (2020-2031)
3.4.3 North America 1-Deoxynojirimycin Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe 1-Deoxynojirimycin Market Facts & Figures by Country
3.5.1 Europe 1-Deoxynojirimycin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe 1-Deoxynojirimycin Sales by Country (2020-2031)
3.5.3 Europe 1-Deoxynojirimycin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 1-Deoxynojirimycin Market Facts & Figures by Region
3.6.1 Asia Pacific 1-Deoxynojirimycin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific 1-Deoxynojirimycin Sales by Region (2020-2031)
3.6.3 Asia Pacific 1-Deoxynojirimycin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America 1-Deoxynojirimycin Market Facts & Figures by Country
3.7.1 Latin America 1-Deoxynojirimycin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America 1-Deoxynojirimycin Sales by Country (2020-2031)
3.7.3 Latin America 1-Deoxynojirimycin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa 1-Deoxynojirimycin Market Facts & Figures by Country
3.8.1 Middle East and Africa 1-Deoxynojirimycin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa 1-Deoxynojirimycin Sales by Country (2020-2031)
3.8.3 Middle East and Africa 1-Deoxynojirimycin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 1-Deoxynojirimycin Sales by Type (2020-2031)
4.1.1 Global 1-Deoxynojirimycin Sales by Type (2020-2025)
4.1.2 Global 1-Deoxynojirimycin Sales by Type (2026-2031)
4.1.3 Global 1-Deoxynojirimycin Sales Market Share by Type (2020-2031)
4.2 Global 1-Deoxynojirimycin Revenue by Type (2020-2031)
4.2.1 Global 1-Deoxynojirimycin Revenue by Type (2020-2025)
4.2.2 Global 1-Deoxynojirimycin Revenue by Type (2026-2031)
4.2.3 Global 1-Deoxynojirimycin Revenue Market Share by Type (2020-2031)
4.3 Global 1-Deoxynojirimycin Price by Type (2020-2031)
5 Segment by Application
5.1 Global 1-Deoxynojirimycin Sales by Application (2020-2031)
5.1.1 Global 1-Deoxynojirimycin Sales by Application (2020-2025)
5.1.2 Global 1-Deoxynojirimycin Sales by Application (2026-2031)
5.1.3 Global 1-Deoxynojirimycin Sales Market Share by Application (2020-2031)
5.2 Global 1-Deoxynojirimycin Revenue by Application (2020-2031)
5.2.1 Global 1-Deoxynojirimycin Revenue by Application (2020-2025)
5.2.2 Global 1-Deoxynojirimycin Revenue by Application (2026-2031)
5.2.3 Global 1-Deoxynojirimycin Revenue Market Share by Application (2020-2031)
5.3 Global 1-Deoxynojirimycin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 TOKYO CHEMICAL INDUSTRY (TCI)
6.1.1 TOKYO CHEMICAL INDUSTRY (TCI) Company Information
6.1.2 TOKYO CHEMICAL INDUSTRY (TCI) Description and Business Overview
6.1.3 TOKYO CHEMICAL INDUSTRY (TCI) 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 TOKYO CHEMICAL INDUSTRY (TCI) 1-Deoxynojirimycin Product Portfolio
6.1.5 TOKYO CHEMICAL INDUSTRY (TCI) Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck 1-Deoxynojirimycin Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Alfa Aesar
6.3.1 Alfa Aesar Company Information
6.3.2 Alfa Aesar Description and Business Overview
6.3.3 Alfa Aesar 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Alfa Aesar 1-Deoxynojirimycin Product Portfolio
6.3.5 Alfa Aesar Recent Developments/Updates
6.4 Biosynth
6.4.1 Biosynth Company Information
6.4.2 Biosynth Description and Business Overview
6.4.3 Biosynth 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biosynth 1-Deoxynojirimycin Product Portfolio
6.4.5 Biosynth Recent Developments/Updates
6.5 Glentham Life Sciences
6.5.1 Glentham Life Sciences Company Information
6.5.2 Glentham Life Sciences Description and Business Overview
6.5.3 Glentham Life Sciences 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Glentham Life Sciences 1-Deoxynojirimycin Product Portfolio
6.5.5 Glentham Life Sciences Recent Developments/Updates
6.6 LGC Group
6.6.1 LGC Group Company Information
6.6.2 LGC Group Description and Business Overview
6.6.3 LGC Group 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 LGC Group 1-Deoxynojirimycin Product Portfolio
6.6.5 LGC Group Recent Developments/Updates
6.7 MedChemExpress
6.7.1 MedChemExpress Company Information
6.7.2 MedChemExpress Description and Business Overview
6.7.3 MedChemExpress 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 MedChemExpress 1-Deoxynojirimycin Product Portfolio
6.7.5 MedChemExpress Recent Developments/Updates
6.8 Cayman Chemical
6.8.1 Cayman Chemical Company Information
6.8.2 Cayman Chemical Description and Business Overview
6.8.3 Cayman Chemical 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cayman Chemical 1-Deoxynojirimycin Product Portfolio
6.8.5 Cayman Chemical Recent Developments/Updates
6.9 ALB Materials
6.9.1 ALB Materials Company Information
6.9.2 ALB Materials Description and Business Overview
6.9.3 ALB Materials 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 ALB Materials 1-Deoxynojirimycin Product Portfolio
6.9.5 ALB Materials Recent Developments/Updates
6.10 PhytoLab
6.10.1 PhytoLab Company Information
6.10.2 PhytoLab Description and Business Overview
6.10.3 PhytoLab 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 PhytoLab 1-Deoxynojirimycin Product Portfolio
6.10.5 PhytoLab Recent Developments/Updates
6.11 TargetMol
6.11.1 TargetMol Company Information
6.11.2 TargetMol Description and Business Overview
6.11.3 TargetMol 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 TargetMol 1-Deoxynojirimycin Product Portfolio
6.11.5 TargetMol Recent Developments/Updates
6.12 Fluorochem
6.12.1 Fluorochem Company Information
6.12.2 Fluorochem Description and Business Overview
6.12.3 Fluorochem 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Fluorochem 1-Deoxynojirimycin Product Portfolio
6.12.5 Fluorochem Recent Developments/Updates
6.13 Yunmei Technology
6.13.1 Yunmei Technology Company Information
6.13.2 Yunmei Technology Description and Business Overview
6.13.3 Yunmei Technology 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Yunmei Technology 1-Deoxynojirimycin Product Portfolio
6.13.5 Yunmei Technology Recent Developments/Updates
6.14 TLC Pharmaceutical Standards
6.14.1 TLC Pharmaceutical Standards Company Information
6.14.2 TLC Pharmaceutical Standards Description and Business Overview
6.14.3 TLC Pharmaceutical Standards 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 TLC Pharmaceutical Standards 1-Deoxynojirimycin Product Portfolio
6.14.5 TLC Pharmaceutical Standards Recent Developments/Updates
6.15 Apollo Scientific
6.15.1 Apollo Scientific Company Information
6.15.2 Apollo Scientific Description and Business Overview
6.15.3 Apollo Scientific 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Apollo Scientific 1-Deoxynojirimycin Product Portfolio
6.15.5 Apollo Scientific Recent Developments/Updates
6.16 Macklin
6.16.1 Macklin Company Information
6.16.2 Macklin Description and Business Overview
6.16.3 Macklin 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Macklin 1-Deoxynojirimycin Product Portfolio
6.16.5 Macklin Recent Developments/Updates
6.17 Chengdu Must Bio-technology
6.17.1 Chengdu Must Bio-technology Company Information
6.17.2 Chengdu Must Bio-technology Description and Business Overview
6.17.3 Chengdu Must Bio-technology 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Chengdu Must Bio-technology 1-Deoxynojirimycin Product Portfolio
6.17.5 Chengdu Must Bio-technology Recent Developments/Updates
6.18 Bidepharm
6.18.1 Bidepharm Company Information
6.18.2 Bidepharm Description and Business Overview
6.18.3 Bidepharm 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Bidepharm 1-Deoxynojirimycin Product Portfolio
6.18.5 Bidepharm Recent Developments/Updates
6.19 Geneham Pharmaceutical
6.19.1 Geneham Pharmaceutical Company Information
6.19.2 Geneham Pharmaceutical Description and Business Overview
6.19.3 Geneham Pharmaceutical 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Geneham Pharmaceutical 1-Deoxynojirimycin Product Portfolio
6.19.5 Geneham Pharmaceutical Recent Developments/Updates
6.20 AstaTech
6.20.1 AstaTech Company Information
6.20.2 AstaTech Description and Business Overview
6.20.3 AstaTech 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.20.4 AstaTech 1-Deoxynojirimycin Product Portfolio
6.20.5 AstaTech Recent Developments/Updates
6.21 Combi-Blocks
6.21.1 Combi-Blocks Company Information
6.21.2 Combi-Blocks Description and Business Overview
6.21.3 Combi-Blocks 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Combi-Blocks 1-Deoxynojirimycin Product Portfolio
6.21.5 Combi-Blocks Recent Developments/Updates
6.22 Pharmablock
6.22.1 Pharmablock Company Information
6.22.2 Pharmablock Description and Business Overview
6.22.3 Pharmablock 1-Deoxynojirimycin Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Pharmablock 1-Deoxynojirimycin Product Portfolio
6.22.5 Pharmablock Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 1-Deoxynojirimycin Industry Chain Analysis
7.2 1-Deoxynojirimycin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 1-Deoxynojirimycin Production Mode & Process Analysis
7.4 1-Deoxynojirimycin Sales and Marketing
7.4.1 1-Deoxynojirimycin Sales Channels
7.4.2 1-Deoxynojirimycin Distributors
7.5 1-Deoxynojirimycin Customer Analysis
8 1-Deoxynojirimycin Market Dynamics
8.1 1-Deoxynojirimycin Industry Trends
8.2 1-Deoxynojirimycin Market Drivers
8.3 1-Deoxynojirimycin Market Challenges
8.4 1-Deoxynojirimycin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global 1-Deoxynojirimycin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global 1-Deoxynojirimycin Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global 1-Deoxynojirimycin Market Competitive Situation by Manufacturers in 2024
Table 4. Global 1-Deoxynojirimycin Sales (Kg) of Key Manufacturers (2020-2025)
Table 5. Global 1-Deoxynojirimycin Sales Market Share by Manufacturers (2020-2025)
Table 6. Global 1-Deoxynojirimycin Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global 1-Deoxynojirimycin Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market 1-Deoxynojirimycin Average Price (US$/g) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of 1-Deoxynojirimycin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of 1-Deoxynojirimycin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of 1-Deoxynojirimycin, Product Type & Application
Table 12. Global Key Manufacturers of 1-Deoxynojirimycin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global 1-Deoxynojirimycin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 1-Deoxynojirimycin as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global 1-Deoxynojirimycin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global 1-Deoxynojirimycin Sales by Region (2020-2025) & (Kg)
Table 18. Global 1-Deoxynojirimycin Sales Market Share by Region (2020-2025)
Table 19. Global 1-Deoxynojirimycin Sales by Region (2026-2031) & (Kg)
Table 20. Global 1-Deoxynojirimycin Sales Market Share by Region (2026-2031)
Table 21. Global 1-Deoxynojirimycin Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global 1-Deoxynojirimycin Revenue Market Share by Region (2020-2025)
Table 23. Global 1-Deoxynojirimycin Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global 1-Deoxynojirimycin Revenue Market Share by Region (2026-2031)
Table 25. North America 1-Deoxynojirimycin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America 1-Deoxynojirimycin Sales by Country (2020-2025) & (Kg)
Table 27. North America 1-Deoxynojirimycin Sales by Country (2026-2031) & (Kg)
Table 28. North America 1-Deoxynojirimycin Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America 1-Deoxynojirimycin Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe 1-Deoxynojirimycin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe 1-Deoxynojirimycin Sales by Country (2020-2025) & (Kg)
Table 32. Europe 1-Deoxynojirimycin Sales by Country (2026-2031) & (Kg)
Table 33. Europe 1-Deoxynojirimycin Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe 1-Deoxynojirimycin Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific 1-Deoxynojirimycin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific 1-Deoxynojirimycin Sales by Region (2020-2025) & (Kg)
Table 37. Asia Pacific 1-Deoxynojirimycin Sales by Region (2026-2031) & (Kg)
Table 38. Asia Pacific 1-Deoxynojirimycin Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific 1-Deoxynojirimycin Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America 1-Deoxynojirimycin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America 1-Deoxynojirimycin Sales by Country (2020-2025) & (Kg)
Table 42. Latin America 1-Deoxynojirimycin Sales by Country (2026-2031) & (Kg)
Table 43. Latin America 1-Deoxynojirimycin Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America 1-Deoxynojirimycin Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa 1-Deoxynojirimycin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa 1-Deoxynojirimycin Sales by Country (2020-2025) & (Kg)
Table 47. Middle East and Africa 1-Deoxynojirimycin Sales by Country (2026-2031) & (Kg)
Table 48. Middle East and Africa 1-Deoxynojirimycin Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa 1-Deoxynojirimycin Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global 1-Deoxynojirimycin Sales (Kg) by Type (2020-2025)
Table 51. Global 1-Deoxynojirimycin Sales (Kg) by Type (2026-2031)
Table 52. Global 1-Deoxynojirimycin Sales Market Share by Type (2020-2025)
Table 53. Global 1-Deoxynojirimycin Sales Market Share by Type (2026-2031)
Table 54. Global 1-Deoxynojirimycin Revenue (US$ Million) by Type (2020-2025)
Table 55. Global 1-Deoxynojirimycin Revenue (US$ Million) by Type (2026-2031)
Table 56. Global 1-Deoxynojirimycin Revenue Market Share by Type (2020-2025)
Table 57. Global 1-Deoxynojirimycin Revenue Market Share by Type (2026-2031)
Table 58. Global 1-Deoxynojirimycin Price (US$/g) by Type (2020-2025)
Table 59. Global 1-Deoxynojirimycin Price (US$/g) by Type (2026-2031)
Table 60. Global 1-Deoxynojirimycin Sales (Kg) by Application (2020-2025)
Table 61. Global 1-Deoxynojirimycin Sales (Kg) by Application (2026-2031)
Table 62. Global 1-Deoxynojirimycin Sales Market Share by Application (2020-2025)
Table 63. Global 1-Deoxynojirimycin Sales Market Share by Application (2026-2031)
Table 64. Global 1-Deoxynojirimycin Revenue (US$ Million) by Application (2020-2025)
Table 65. Global 1-Deoxynojirimycin Revenue (US$ Million) by Application (2026-2031)
Table 66. Global 1-Deoxynojirimycin Revenue Market Share by Application (2020-2025)
Table 67. Global 1-Deoxynojirimycin Revenue Market Share by Application (2026-2031)
Table 68. Global 1-Deoxynojirimycin Price (US$/g) by Application (2020-2025)
Table 69. Global 1-Deoxynojirimycin Price (US$/g) by Application (2026-2031)
Table 70. TOKYO CHEMICAL INDUSTRY (TCI) Company Information
Table 71. TOKYO CHEMICAL INDUSTRY (TCI) Description and Business Overview
Table 72. TOKYO CHEMICAL INDUSTRY (TCI) 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 73. TOKYO CHEMICAL INDUSTRY (TCI) 1-Deoxynojirimycin Product
Table 74. TOKYO CHEMICAL INDUSTRY (TCI) Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 78. Merck 1-Deoxynojirimycin Product
Table 79. Merck Recent Developments/Updates
Table 80. Alfa Aesar Company Information
Table 81. Alfa Aesar Description and Business Overview
Table 82. Alfa Aesar 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 83. Alfa Aesar 1-Deoxynojirimycin Product
Table 84. Alfa Aesar Recent Developments/Updates
Table 85. Biosynth Company Information
Table 86. Biosynth Description and Business Overview
Table 87. Biosynth 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 88. Biosynth 1-Deoxynojirimycin Product
Table 89. Biosynth Recent Developments/Updates
Table 90. Glentham Life Sciences Company Information
Table 91. Glentham Life Sciences Description and Business Overview
Table 92. Glentham Life Sciences 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 93. Glentham Life Sciences 1-Deoxynojirimycin Product
Table 94. Glentham Life Sciences Recent Developments/Updates
Table 95. LGC Group Company Information
Table 96. LGC Group Description and Business Overview
Table 97. LGC Group 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 98. LGC Group 1-Deoxynojirimycin Product
Table 99. LGC Group Recent Developments/Updates
Table 100. MedChemExpress Company Information
Table 101. MedChemExpress Description and Business Overview
Table 102. MedChemExpress 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 103. MedChemExpress 1-Deoxynojirimycin Product
Table 104. MedChemExpress Recent Developments/Updates
Table 105. Cayman Chemical Company Information
Table 106. Cayman Chemical Description and Business Overview
Table 107. Cayman Chemical 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 108. Cayman Chemical 1-Deoxynojirimycin Product
Table 109. Cayman Chemical Recent Developments/Updates
Table 110. ALB Materials Company Information
Table 111. ALB Materials Description and Business Overview
Table 112. ALB Materials 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 113. ALB Materials 1-Deoxynojirimycin Product
Table 114. ALB Materials Recent Developments/Updates
Table 115. PhytoLab Company Information
Table 116. PhytoLab Description and Business Overview
Table 117. PhytoLab 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 118. PhytoLab 1-Deoxynojirimycin Product
Table 119. PhytoLab Recent Developments/Updates
Table 120. TargetMol Company Information
Table 121. TargetMol Description and Business Overview
Table 122. TargetMol 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 123. TargetMol 1-Deoxynojirimycin Product
Table 124. TargetMol Recent Developments/Updates
Table 125. Fluorochem Company Information
Table 126. Fluorochem Description and Business Overview
Table 127. Fluorochem 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 128. Fluorochem 1-Deoxynojirimycin Product
Table 129. Fluorochem Recent Developments/Updates
Table 130. Yunmei Technology Company Information
Table 131. Yunmei Technology Description and Business Overview
Table 132. Yunmei Technology 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 133. Yunmei Technology 1-Deoxynojirimycin Product
Table 134. Yunmei Technology Recent Developments/Updates
Table 135. TLC Pharmaceutical Standards Company Information
Table 136. TLC Pharmaceutical Standards Description and Business Overview
Table 137. TLC Pharmaceutical Standards 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 138. TLC Pharmaceutical Standards 1-Deoxynojirimycin Product
Table 139. TLC Pharmaceutical Standards Recent Developments/Updates
Table 140. Apollo Scientific Company Information
Table 141. Apollo Scientific Description and Business Overview
Table 142. Apollo Scientific 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 143. Apollo Scientific 1-Deoxynojirimycin Product
Table 144. Apollo Scientific Recent Developments/Updates
Table 145. Macklin Company Information
Table 146. Macklin Description and Business Overview
Table 147. Macklin 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 148. Macklin 1-Deoxynojirimycin Product
Table 149. Macklin Recent Developments/Updates
Table 150. Chengdu Must Bio-technology Company Information
Table 151. Chengdu Must Bio-technology Description and Business Overview
Table 152. Chengdu Must Bio-technology 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 153. Chengdu Must Bio-technology 1-Deoxynojirimycin Product
Table 154. Chengdu Must Bio-technology Recent Developments/Updates
Table 155. Bidepharm Company Information
Table 156. Bidepharm Description and Business Overview
Table 157. Bidepharm 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 158. Bidepharm 1-Deoxynojirimycin Product
Table 159. Bidepharm Recent Developments/Updates
Table 160. Geneham Pharmaceutical Company Information
Table 161. Geneham Pharmaceutical Description and Business Overview
Table 162. Geneham Pharmaceutical 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 163. Geneham Pharmaceutical 1-Deoxynojirimycin Product
Table 164. Geneham Pharmaceutical Recent Developments/Updates
Table 165. AstaTech Company Information
Table 166. AstaTech Description and Business Overview
Table 167. AstaTech 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 168. AstaTech 1-Deoxynojirimycin Product
Table 169. AstaTech Recent Developments/Updates
Table 170. Combi-Blocks Company Information
Table 171. Combi-Blocks Description and Business Overview
Table 172. Combi-Blocks 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 173. Combi-Blocks 1-Deoxynojirimycin Product
Table 174. Combi-Blocks Recent Developments/Updates
Table 175. Pharmablock Company Information
Table 176. Pharmablock Description and Business Overview
Table 177. Pharmablock 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 178. Pharmablock 1-Deoxynojirimycin Product
Table 179. Pharmablock Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. 1-Deoxynojirimycin Distributors List
Table 183. 1-Deoxynojirimycin Customers List
Table 184. 1-Deoxynojirimycin Market Trends
Table 185. 1-Deoxynojirimycin Market Drivers
Table 186. 1-Deoxynojirimycin Market Challenges
Table 187. 1-Deoxynojirimycin Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
Table 191. Authors List of This Report
List of Figures
Figure 1. Product Picture of 1-Deoxynojirimycin
Figure 2. Global 1-Deoxynojirimycin Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global 1-Deoxynojirimycin Market Share by Type: 2024 & 2031
Figure 4. 95%-98% (Including 95% and 98%) Product Picture
Figure 5. Above 98% Product Picture
Figure 6. Global 1-Deoxynojirimycin Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global 1-Deoxynojirimycin Market Share by Application: 2024 & 2031
Figure 8. Scientific Research
Figure 9. Anti-diabetic Drugs
Figure 10. Others
Figure 11. Global 1-Deoxynojirimycin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global 1-Deoxynojirimycin Market Size (2020-2031) & (US$ Million)
Figure 13. Global 1-Deoxynojirimycin Sales (2020-2031) & (Kg)
Figure 14. Global 1-Deoxynojirimycin Average Price (US$/g) & (2020-2031)
Figure 15. 1-Deoxynojirimycin Report Years Considered
Figure 16. 1-Deoxynojirimycin Sales Share by Manufacturers in 2024
Figure 17. Global 1-Deoxynojirimycin Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest 1-Deoxynojirimycin Players: Market Share by Revenue in 1-Deoxynojirimycin in 2024
Figure 19. 1-Deoxynojirimycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global 1-Deoxynojirimycin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America 1-Deoxynojirimycin Sales Market Share by Country (2020-2031)
Figure 22. North America 1-Deoxynojirimycin Revenue Market Share by Country (2020-2031)
Figure 23. United States 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe 1-Deoxynojirimycin Sales Market Share by Country (2020-2031)
Figure 26. Europe 1-Deoxynojirimycin Revenue Market Share by Country (2020-2031)
Figure 27. Germany 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific 1-Deoxynojirimycin Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific 1-Deoxynojirimycin Revenue Market Share by Region (2020-2031)
Figure 34. China 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America 1-Deoxynojirimycin Sales Market Share by Country (2020-2031)
Figure 42. Latin America 1-Deoxynojirimycin Revenue Market Share by Country (2020-2031)
Figure 43. Mexico 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa 1-Deoxynojirimycin Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa 1-Deoxynojirimycin Revenue Market Share by Country (2020-2031)
Figure 48. Turkey 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of 1-Deoxynojirimycin by Type (2020-2031)
Figure 52. Global Revenue Market Share of 1-Deoxynojirimycin by Type (2020-2031)
Figure 53. Global 1-Deoxynojirimycin Price (US$/g) by Type (2020-2031)
Figure 54. Global Sales Market Share of 1-Deoxynojirimycin by Application (2020-2031)
Figure 55. Global Revenue Market Share of 1-Deoxynojirimycin by Application (2020-2031)
Figure 56. Global 1-Deoxynojirimycin Price (US$/g) by Application (2020-2031)
Figure 57. 1-Deoxynojirimycin Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global 1-Deoxynojirimycin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global 1-Deoxynojirimycin Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global 1-Deoxynojirimycin Market Competitive Situation by Manufacturers in 2024
Table 4. Global 1-Deoxynojirimycin Sales (Kg) of Key Manufacturers (2020-2025)
Table 5. Global 1-Deoxynojirimycin Sales Market Share by Manufacturers (2020-2025)
Table 6. Global 1-Deoxynojirimycin Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global 1-Deoxynojirimycin Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market 1-Deoxynojirimycin Average Price (US$/g) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of 1-Deoxynojirimycin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of 1-Deoxynojirimycin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of 1-Deoxynojirimycin, Product Type & Application
Table 12. Global Key Manufacturers of 1-Deoxynojirimycin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global 1-Deoxynojirimycin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 1-Deoxynojirimycin as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global 1-Deoxynojirimycin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global 1-Deoxynojirimycin Sales by Region (2020-2025) & (Kg)
Table 18. Global 1-Deoxynojirimycin Sales Market Share by Region (2020-2025)
Table 19. Global 1-Deoxynojirimycin Sales by Region (2026-2031) & (Kg)
Table 20. Global 1-Deoxynojirimycin Sales Market Share by Region (2026-2031)
Table 21. Global 1-Deoxynojirimycin Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global 1-Deoxynojirimycin Revenue Market Share by Region (2020-2025)
Table 23. Global 1-Deoxynojirimycin Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global 1-Deoxynojirimycin Revenue Market Share by Region (2026-2031)
Table 25. North America 1-Deoxynojirimycin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America 1-Deoxynojirimycin Sales by Country (2020-2025) & (Kg)
Table 27. North America 1-Deoxynojirimycin Sales by Country (2026-2031) & (Kg)
Table 28. North America 1-Deoxynojirimycin Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America 1-Deoxynojirimycin Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe 1-Deoxynojirimycin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe 1-Deoxynojirimycin Sales by Country (2020-2025) & (Kg)
Table 32. Europe 1-Deoxynojirimycin Sales by Country (2026-2031) & (Kg)
Table 33. Europe 1-Deoxynojirimycin Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe 1-Deoxynojirimycin Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific 1-Deoxynojirimycin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific 1-Deoxynojirimycin Sales by Region (2020-2025) & (Kg)
Table 37. Asia Pacific 1-Deoxynojirimycin Sales by Region (2026-2031) & (Kg)
Table 38. Asia Pacific 1-Deoxynojirimycin Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific 1-Deoxynojirimycin Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America 1-Deoxynojirimycin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America 1-Deoxynojirimycin Sales by Country (2020-2025) & (Kg)
Table 42. Latin America 1-Deoxynojirimycin Sales by Country (2026-2031) & (Kg)
Table 43. Latin America 1-Deoxynojirimycin Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America 1-Deoxynojirimycin Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa 1-Deoxynojirimycin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa 1-Deoxynojirimycin Sales by Country (2020-2025) & (Kg)
Table 47. Middle East and Africa 1-Deoxynojirimycin Sales by Country (2026-2031) & (Kg)
Table 48. Middle East and Africa 1-Deoxynojirimycin Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa 1-Deoxynojirimycin Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global 1-Deoxynojirimycin Sales (Kg) by Type (2020-2025)
Table 51. Global 1-Deoxynojirimycin Sales (Kg) by Type (2026-2031)
Table 52. Global 1-Deoxynojirimycin Sales Market Share by Type (2020-2025)
Table 53. Global 1-Deoxynojirimycin Sales Market Share by Type (2026-2031)
Table 54. Global 1-Deoxynojirimycin Revenue (US$ Million) by Type (2020-2025)
Table 55. Global 1-Deoxynojirimycin Revenue (US$ Million) by Type (2026-2031)
Table 56. Global 1-Deoxynojirimycin Revenue Market Share by Type (2020-2025)
Table 57. Global 1-Deoxynojirimycin Revenue Market Share by Type (2026-2031)
Table 58. Global 1-Deoxynojirimycin Price (US$/g) by Type (2020-2025)
Table 59. Global 1-Deoxynojirimycin Price (US$/g) by Type (2026-2031)
Table 60. Global 1-Deoxynojirimycin Sales (Kg) by Application (2020-2025)
Table 61. Global 1-Deoxynojirimycin Sales (Kg) by Application (2026-2031)
Table 62. Global 1-Deoxynojirimycin Sales Market Share by Application (2020-2025)
Table 63. Global 1-Deoxynojirimycin Sales Market Share by Application (2026-2031)
Table 64. Global 1-Deoxynojirimycin Revenue (US$ Million) by Application (2020-2025)
Table 65. Global 1-Deoxynojirimycin Revenue (US$ Million) by Application (2026-2031)
Table 66. Global 1-Deoxynojirimycin Revenue Market Share by Application (2020-2025)
Table 67. Global 1-Deoxynojirimycin Revenue Market Share by Application (2026-2031)
Table 68. Global 1-Deoxynojirimycin Price (US$/g) by Application (2020-2025)
Table 69. Global 1-Deoxynojirimycin Price (US$/g) by Application (2026-2031)
Table 70. TOKYO CHEMICAL INDUSTRY (TCI) Company Information
Table 71. TOKYO CHEMICAL INDUSTRY (TCI) Description and Business Overview
Table 72. TOKYO CHEMICAL INDUSTRY (TCI) 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 73. TOKYO CHEMICAL INDUSTRY (TCI) 1-Deoxynojirimycin Product
Table 74. TOKYO CHEMICAL INDUSTRY (TCI) Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 78. Merck 1-Deoxynojirimycin Product
Table 79. Merck Recent Developments/Updates
Table 80. Alfa Aesar Company Information
Table 81. Alfa Aesar Description and Business Overview
Table 82. Alfa Aesar 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 83. Alfa Aesar 1-Deoxynojirimycin Product
Table 84. Alfa Aesar Recent Developments/Updates
Table 85. Biosynth Company Information
Table 86. Biosynth Description and Business Overview
Table 87. Biosynth 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 88. Biosynth 1-Deoxynojirimycin Product
Table 89. Biosynth Recent Developments/Updates
Table 90. Glentham Life Sciences Company Information
Table 91. Glentham Life Sciences Description and Business Overview
Table 92. Glentham Life Sciences 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 93. Glentham Life Sciences 1-Deoxynojirimycin Product
Table 94. Glentham Life Sciences Recent Developments/Updates
Table 95. LGC Group Company Information
Table 96. LGC Group Description and Business Overview
Table 97. LGC Group 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 98. LGC Group 1-Deoxynojirimycin Product
Table 99. LGC Group Recent Developments/Updates
Table 100. MedChemExpress Company Information
Table 101. MedChemExpress Description and Business Overview
Table 102. MedChemExpress 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 103. MedChemExpress 1-Deoxynojirimycin Product
Table 104. MedChemExpress Recent Developments/Updates
Table 105. Cayman Chemical Company Information
Table 106. Cayman Chemical Description and Business Overview
Table 107. Cayman Chemical 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 108. Cayman Chemical 1-Deoxynojirimycin Product
Table 109. Cayman Chemical Recent Developments/Updates
Table 110. ALB Materials Company Information
Table 111. ALB Materials Description and Business Overview
Table 112. ALB Materials 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 113. ALB Materials 1-Deoxynojirimycin Product
Table 114. ALB Materials Recent Developments/Updates
Table 115. PhytoLab Company Information
Table 116. PhytoLab Description and Business Overview
Table 117. PhytoLab 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 118. PhytoLab 1-Deoxynojirimycin Product
Table 119. PhytoLab Recent Developments/Updates
Table 120. TargetMol Company Information
Table 121. TargetMol Description and Business Overview
Table 122. TargetMol 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 123. TargetMol 1-Deoxynojirimycin Product
Table 124. TargetMol Recent Developments/Updates
Table 125. Fluorochem Company Information
Table 126. Fluorochem Description and Business Overview
Table 127. Fluorochem 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 128. Fluorochem 1-Deoxynojirimycin Product
Table 129. Fluorochem Recent Developments/Updates
Table 130. Yunmei Technology Company Information
Table 131. Yunmei Technology Description and Business Overview
Table 132. Yunmei Technology 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 133. Yunmei Technology 1-Deoxynojirimycin Product
Table 134. Yunmei Technology Recent Developments/Updates
Table 135. TLC Pharmaceutical Standards Company Information
Table 136. TLC Pharmaceutical Standards Description and Business Overview
Table 137. TLC Pharmaceutical Standards 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 138. TLC Pharmaceutical Standards 1-Deoxynojirimycin Product
Table 139. TLC Pharmaceutical Standards Recent Developments/Updates
Table 140. Apollo Scientific Company Information
Table 141. Apollo Scientific Description and Business Overview
Table 142. Apollo Scientific 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 143. Apollo Scientific 1-Deoxynojirimycin Product
Table 144. Apollo Scientific Recent Developments/Updates
Table 145. Macklin Company Information
Table 146. Macklin Description and Business Overview
Table 147. Macklin 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 148. Macklin 1-Deoxynojirimycin Product
Table 149. Macklin Recent Developments/Updates
Table 150. Chengdu Must Bio-technology Company Information
Table 151. Chengdu Must Bio-technology Description and Business Overview
Table 152. Chengdu Must Bio-technology 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 153. Chengdu Must Bio-technology 1-Deoxynojirimycin Product
Table 154. Chengdu Must Bio-technology Recent Developments/Updates
Table 155. Bidepharm Company Information
Table 156. Bidepharm Description and Business Overview
Table 157. Bidepharm 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 158. Bidepharm 1-Deoxynojirimycin Product
Table 159. Bidepharm Recent Developments/Updates
Table 160. Geneham Pharmaceutical Company Information
Table 161. Geneham Pharmaceutical Description and Business Overview
Table 162. Geneham Pharmaceutical 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 163. Geneham Pharmaceutical 1-Deoxynojirimycin Product
Table 164. Geneham Pharmaceutical Recent Developments/Updates
Table 165. AstaTech Company Information
Table 166. AstaTech Description and Business Overview
Table 167. AstaTech 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 168. AstaTech 1-Deoxynojirimycin Product
Table 169. AstaTech Recent Developments/Updates
Table 170. Combi-Blocks Company Information
Table 171. Combi-Blocks Description and Business Overview
Table 172. Combi-Blocks 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 173. Combi-Blocks 1-Deoxynojirimycin Product
Table 174. Combi-Blocks Recent Developments/Updates
Table 175. Pharmablock Company Information
Table 176. Pharmablock Description and Business Overview
Table 177. Pharmablock 1-Deoxynojirimycin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 178. Pharmablock 1-Deoxynojirimycin Product
Table 179. Pharmablock Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. 1-Deoxynojirimycin Distributors List
Table 183. 1-Deoxynojirimycin Customers List
Table 184. 1-Deoxynojirimycin Market Trends
Table 185. 1-Deoxynojirimycin Market Drivers
Table 186. 1-Deoxynojirimycin Market Challenges
Table 187. 1-Deoxynojirimycin Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
Table 191. Authors List of This Report
List of Figures
Figure 1. Product Picture of 1-Deoxynojirimycin
Figure 2. Global 1-Deoxynojirimycin Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global 1-Deoxynojirimycin Market Share by Type: 2024 & 2031
Figure 4. 95%-98% (Including 95% and 98%) Product Picture
Figure 5. Above 98% Product Picture
Figure 6. Global 1-Deoxynojirimycin Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global 1-Deoxynojirimycin Market Share by Application: 2024 & 2031
Figure 8. Scientific Research
Figure 9. Anti-diabetic Drugs
Figure 10. Others
Figure 11. Global 1-Deoxynojirimycin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global 1-Deoxynojirimycin Market Size (2020-2031) & (US$ Million)
Figure 13. Global 1-Deoxynojirimycin Sales (2020-2031) & (Kg)
Figure 14. Global 1-Deoxynojirimycin Average Price (US$/g) & (2020-2031)
Figure 15. 1-Deoxynojirimycin Report Years Considered
Figure 16. 1-Deoxynojirimycin Sales Share by Manufacturers in 2024
Figure 17. Global 1-Deoxynojirimycin Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest 1-Deoxynojirimycin Players: Market Share by Revenue in 1-Deoxynojirimycin in 2024
Figure 19. 1-Deoxynojirimycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global 1-Deoxynojirimycin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America 1-Deoxynojirimycin Sales Market Share by Country (2020-2031)
Figure 22. North America 1-Deoxynojirimycin Revenue Market Share by Country (2020-2031)
Figure 23. United States 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe 1-Deoxynojirimycin Sales Market Share by Country (2020-2031)
Figure 26. Europe 1-Deoxynojirimycin Revenue Market Share by Country (2020-2031)
Figure 27. Germany 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific 1-Deoxynojirimycin Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific 1-Deoxynojirimycin Revenue Market Share by Region (2020-2031)
Figure 34. China 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America 1-Deoxynojirimycin Sales Market Share by Country (2020-2031)
Figure 42. Latin America 1-Deoxynojirimycin Revenue Market Share by Country (2020-2031)
Figure 43. Mexico 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa 1-Deoxynojirimycin Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa 1-Deoxynojirimycin Revenue Market Share by Country (2020-2031)
Figure 48. Turkey 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE 1-Deoxynojirimycin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of 1-Deoxynojirimycin by Type (2020-2031)
Figure 52. Global Revenue Market Share of 1-Deoxynojirimycin by Type (2020-2031)
Figure 53. Global 1-Deoxynojirimycin Price (US$/g) by Type (2020-2031)
Figure 54. Global Sales Market Share of 1-Deoxynojirimycin by Application (2020-2031)
Figure 55. Global Revenue Market Share of 1-Deoxynojirimycin by Application (2020-2031)
Figure 56. Global 1-Deoxynojirimycin Price (US$/g) by Application (2020-2031)
Figure 57. 1-Deoxynojirimycin Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232